Gene · 4055
Papers3,299
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,299
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TNFR Pathway-Related Proteins and Recurrent Coronary Artery Disease Events. | JACC Adv | 2026 | 41863207 | PubTator, text mining | PubMed |
| Inflammatory protein profiling in immune cells identifies molecular signatures for enhanced diagnostic precision in psoriatic arthritis. | Mol Biomed | 2026 | 41851388 | PubTator, text mining | PubMed |
| RASSF1A inhibits gastric cancer metastasis by reducing neutrophil infiltration and neutrophil extracellular trap formation via ribosome biogenesis. | Int Immunopharmacol | 2026 | 41833106 | PubTator, text mining | PubMed |
| The Role of Neutrophils in Non-Alcoholic Fatty Liver Disease: Mechanisms and Clinical Significance. | J Inflamm Res | 2026 | 41809765 | PubTator, text mining | PubMed |
| Plasma proteomic profile reveals persistent immune activation in post-acute sequelae of SARS-CoV-2 infection. | Front Immunol | 2026 | 41808838 | PubTator, text mining | PubMed |
| New Insights into the Role of NF-κB in Hepatitis B Virus Infection. | Int J Biol Sci | 2026 | 41800244 | PubTator, text mining | PubMed |
| Tumor Cells as Architects of Immune Refractoriness: Dismantling Intrinsic Programs of Tumor Cells for Clinical Translation. | Immune Netw | 2026 | 41800027 | PubTator, text mining | PubMed |
| Finding Significant Hits in Networks: a network-based tool for analyzing gene-level P-values to identify significant genes missed by standard methods. | Brief Bioinform | 2026 | 41795654 | PubTator, text mining | PubMed |
| Proximity extension assay-based targeted proteomics for biomarker discovery in adult bacterial infections. | Front Cell Infect Microbiol | 2026 | 41769342 | PubTator, text mining | PubMed |
| Clinical, Prognostic, and Biological Features of High-Risk Cardiometabolic Phenotype: The REMODEL Study. | MedComm (2020) | 2026 | 41768368 | PubTator, text mining | PubMed |
| Initiation of Tertiary Lymphoid Structures for Cancer Immunotherapy. | Research (Wash D C) | 2026 | 41756723 | PubTator, text mining | PubMed |
| Self-Assembled Hydrogels: A Novel Drug Delivery System for Osteoarthritis. | Curr Issues Mol Biol | 2026 | 41751473 | PubTator, text mining | PubMed |
| The Role of CD4+ T Helper Cell Subsets in Hepatocellular Carcinoma: Implications for Tumour Progression and Immunotherapy. | Cells | 2026 | 41744794 | PubTator, text mining | PubMed |
| Tertiary lymphoid structures in glioblastoma: Association with multiparametric MRI imaging phenotypic features and patient survival. | Neurooncol Adv | 2026 | 41727339 | PubTator, text mining | PubMed |
| Advancing CAR-T therapy in prostate cancer: overcoming the tumor microenvironment and enhancing efficacy. | Front Oncol | 2026 | 41717407 | PubTator, text mining | PubMed |
| The mechanism and clinical research of vagus nerve electrical stimulation in the treatment of myocardial ischemia-reperfusion injury. | iScience | 2026 | 41716993 | PubTator, text mining | PubMed |
| Pleiotropic and multicellular roles of lymphotoxin beta receptor in solid tumor immunity and therapeutic targeting. | Front Immunol | 2026 | 41716391 | PubTator, text mining | PubMed |
| B cells and iBALT in TB immunity & pathogenesis. | Front Immunol | 2026 | 41716389 | PubTator, text mining | PubMed |
| Engineered mesenchymal stem cells expressing CXCR4 and LIGHT enhance Anti-Tumor activity in a subcutaneous gastric cancer xenograft model. | Med Oncol | 2026 | 41712131 | PubTator, text mining | PubMed |
| The interaction between dendritic cells and T follicular helper cells drives inflammatory bowel disease: a review. | Front Immunol | 2026 | 41710888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4055/papers?page=2